HomeMIRA • NASDAQ
add
Mira Pharmaceuticals Inc
Previous close
$1.33
Day range
$1.25 - $1.33
Year range
$0.51 - $5.01
Market cap
20.87M USD
Avg Volume
527.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.08M | -34.13% |
Net income | -2.04M | 43.03% |
Net profit margin | — | — |
Earnings per share | -0.14 | 46.15% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.14M | -29.37% |
Total assets | 4.27M | -52.69% |
Total liabilities | 692.83K | -23.27% |
Total equity | 3.57M | — |
Shares outstanding | 16.56M | — |
Price to book | 6.05 | — |
Return on assets | -142.93% | — |
Return on capital | -179.68% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.04M | 43.03% |
Cash from operations | -1.84M | -4.59% |
Cash from investing | — | — |
Cash from financing | 3.16M | -58.41% |
Net change in cash | 1.32M | -77.40% |
Free cash flow | -1.38M | 8.71% |
About
Founded
2020
Headquarters
Website
Employees
3
